Filed: 11/10/2022ACC: 0001104659-22-117090
π What this filing means
KNOTT DAVID M JR filed this quarterly 13FβHR report disclosing 184 equity positions with a total reported market value of $237.6K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
184
Positions
$237.6K
Total AUM (reported)
19.39M
Total Shares
Allocation by class
COMMON$237.6K100.0%
Portfolio Concentration
Top 3$81.6K34.3%
4β10$53.1K22.4%
11β25$45.0K18.9%
Rest$58.0K24.4%
Top 3 weight
34.3%
Top 10 weight
56.7%
Voting Authority Distribution
Total shares with voting rights: 19.39M
Sole
Full voting authority
19.39M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other184
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings184
Rows:
Calumet Specialty Products Partners, LP
DFNDShares4.44M
TypeSH
Market value$56.9K
23.93%
Sole
4.44M
Shared
0.00
None
0.00
DocGo, Inc.
DFNDShares1.40M
TypeSH
Market value$13.9K
5.84%
Sole
1.40M
Shared
0.00
None
0.00
Alphabet Inc Class C
DFNDShares112.22K
TypeSH
Market value$10.8K
4.54%
Sole
112.22K
Shared
0.00
None
0.00
Apollo Global Management, Inc.
DFNDShares225K
TypeSH
Market value$10.5K
4.40%
Sole
225K
Shared
0.00
None
0.00
Ligand Pharmaceuticals Incorporated
DFNDShares115K
TypeSH
Market value$9.9K
4.17%
Sole
115K
Shared
0.00
None
0.00
Franklin BSP Realty Trust, Inc.
DFNDShares859.05K
TypeSH
Market value$9.3K
3.89%
Sole
859.05K
Shared
0.00
None
0.00
Fortress Trans & Infrastructure Inv. LLC
DFNDShares425K
TypeSH
Market value$6.4K
2.68%
Sole
425K
Shared
0.00
None
0.00
Pfizer Inc.
DFNDShares143.50K
TypeSH
Market value$6.3K
2.64%
Sole
143.50K
Shared
0.00
None
0.00
Coliseum Acquisition Corp. Wts
DFNDShares495K
TypeSH
Market value$5.7K
2.40%
Sole
495K
Shared
0.00
None
0.00
African Gold Acquistion Corp. Warrants
DFNDShares450.75K
TypeSH
Market value$5.2K
2.18%
Sole
450.75K
Shared
0.00
None
0.00
Midwest Holding Inc.
DFNDShares390.24K
TypeSH
Market value$5.2K
2.17%
Sole
390.24K
Shared
0.00
None
0.00
Vertex Pharmaceuticals, Inc.
DFNDShares17K
TypeSH
Market value$4.9K
2.07%
Sole
17K
Shared
0.00
None
0.00
Johnson & Johnson
DFNDShares24.80K
TypeSH
Market value$4.1K
1.70%
Sole
24.80K
Shared
0.00
None
0.00
CTI BioPharma Corp.
DFNDShares566.69K
TypeSH
Market value$3.3K
1.39%
Sole
566.69K
Shared
0.00
None
0.00
Eiger BioPharmaceuticals, Inc.
DFNDShares409.29K
TypeSH
Market value$3.1K
1.30%
Sole
409.29K
Shared
0.00
None
0.00
Jazz Pharmaceuticals PLC
DFNDShares22.41K
TypeSH
Market value$3.0K
1.26%
Sole
22.41K
Shared
0.00
None
0.00
Glass Houses Acquisition Corp. Warrants
DFNDShares250K
TypeSH
Market value$2.9K
1.21%
Sole
250K
Shared
0.00
None
0.00
Kennedy-Wilson Holdings, Inc.
DFNDShares175K
TypeSH
Market value$2.7K
1.14%
Sole
175K
Shared
0.00
None
0.00
Horizon Therapeutics Public Ltd. Company
DFNDShares43.49K
TypeSH
Market value$2.7K
1.13%
Sole
43.49K
Shared
0.00
None
0.00
AbbVie Inc.
DFNDShares20.04K
TypeSH
Market value$2.7K
1.13%
Sole
20.04K
Shared
0.00
None
0.00
Xenon Pharmaceuticals Inc.
DFNDShares59.50K
TypeSH
Market value$2.1K
0.90%
Sole
59.50K
Shared
0.00
None
0.00
JP Morgan Chase
DFNDShares20.39K
TypeSH
Market value$2.1K
0.90%
Sole
20.39K
Shared
0.00
None
0.00
iPath Series B S&P 500 VIX Short-Term Fut
DFNDShares100K
TypeSH
Market value$2.1K
0.89%
Sole
100K
Shared
0.00
None
0.00
Merck & Co., Inc.
DFNDShares24.50K
TypeSH
Market value$2.1K
0.89%
Sole
24.50K
Shared
0.00
None
0.00
Medicus Science Acquisition, Corp.
DFNDShares200K
TypeSH
Market value$2.0K
0.83%
Sole
200K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting β Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Calumet Specialty Products Partners, LPDFND | Common | 4.44M | SH | $56.9K 23.93% | 4.44M | 0.00 | 0.00 |
DocGo, Inc.DFND | Common | 1.40M | SH | $13.9K 5.84% | 1.40M | 0.00 | 0.00 |
Alphabet Inc Class CDFND | Common | 112.22K | SH | $10.8K 4.54% | 112.22K | 0.00 | 0.00 |
Apollo Global Management, Inc.DFND | Common | 225K | SH | $10.5K 4.40% | 225K | 0.00 | 0.00 |
Ligand Pharmaceuticals IncorporatedDFND | Common | 115K | SH | $9.9K 4.17% | 115K | 0.00 | 0.00 |
Franklin BSP Realty Trust, Inc.DFND | Common | 859.05K | SH | $9.3K 3.89% | 859.05K | 0.00 | 0.00 |
Fortress Trans & Infrastructure Inv. LLCDFND | Common | 425K | SH | $6.4K 2.68% | 425K | 0.00 | 0.00 |
Pfizer Inc.DFND | Common | 143.50K | SH | $6.3K 2.64% | 143.50K | 0.00 | 0.00 |
Coliseum Acquisition Corp. WtsDFND | Common | 495K | SH | $5.7K 2.40% | 495K | 0.00 | 0.00 |
African Gold Acquistion Corp. WarrantsDFND | Common | 450.75K | SH | $5.2K 2.18% | 450.75K | 0.00 | 0.00 |
Midwest Holding Inc.DFND | Common | 390.24K | SH | $5.2K 2.17% | 390.24K | 0.00 | 0.00 |
Vertex Pharmaceuticals, Inc.DFND | Common | 17K | SH | $4.9K 2.07% | 17K | 0.00 | 0.00 |
Johnson & JohnsonDFND | Common | 24.80K | SH | $4.1K 1.70% | 24.80K | 0.00 | 0.00 |
CTI BioPharma Corp.DFND | Common | 566.69K | SH | $3.3K 1.39% | 566.69K | 0.00 | 0.00 |
Eiger BioPharmaceuticals, Inc.DFND | Common | 409.29K | SH | $3.1K 1.30% | 409.29K | 0.00 | 0.00 |
Jazz Pharmaceuticals PLCDFND | Common | 22.41K | SH | $3.0K 1.26% | 22.41K | 0.00 | 0.00 |
Glass Houses Acquisition Corp. WarrantsDFND | Common | 250K | SH | $2.9K 1.21% | 250K | 0.00 | 0.00 |
Kennedy-Wilson Holdings, Inc.DFND | Common | 175K | SH | $2.7K 1.14% | 175K | 0.00 | 0.00 |
Horizon Therapeutics Public Ltd. CompanyDFND | Common | 43.49K | SH | $2.7K 1.13% | 43.49K | 0.00 | 0.00 |
AbbVie Inc.DFND | Common | 20.04K | SH | $2.7K 1.13% | 20.04K | 0.00 | 0.00 |
Xenon Pharmaceuticals Inc.DFND | Common | 59.50K | SH | $2.1K 0.90% | 59.50K | 0.00 | 0.00 |
JP Morgan ChaseDFND | Common | 20.39K | SH | $2.1K 0.90% | 20.39K | 0.00 | 0.00 |
iPath Series B S&P 500 VIX Short-Term FutDFND | Common | 100K | SH | $2.1K 0.89% | 100K | 0.00 | 0.00 |
Merck & Co., Inc.DFND | Common | 24.50K | SH | $2.1K 0.89% | 24.50K | 0.00 | 0.00 |
Medicus Science Acquisition, Corp.DFND | Common | 200K | SH | $2.0K 0.83% | 200K | 0.00 | 0.00 |
Page 1 of 8
β¦